Cargando…
Impact of treatment with dimethyl fumarate on sleep quality in patients with relapsing-remitting multiple sclerosis: A multicentre Italian wearable tracker study
BACKGROUND: Sleep disorders are common in patients with multiple sclerosis and have a bidirectional interplay with fatigue and depression. OBJECTIVE: To evaluate the effect of treatment with oral dimethyl fumarate on the quality of sleep in relapsing-remitting multiple sclerosis. METHODS: This was a...
Autores principales: | Comi, Giancarlo, Leocani, Letizia, Ferini-Strambi, Luigi, Radaelli, Marta, Costa, Gloria D, Lanzillo, Roberta, Lus, Giacomo, Bianchi, Valentina, Traccis, Sebastiano, Capone, Fioravante, Grimaldi, Luigi ME, Salemi, Giuseppe, Cardillo, Alessandra, Zipoli, Valentina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912562/ https://www.ncbi.nlm.nih.gov/pubmed/36776745 http://dx.doi.org/10.1177/20552173221144229 |
Ejemplares similares
-
Neuropathic Pain and Sleep: A Review
por: Ferini-Strambi, Luigi
Publicado: (2017) -
Sleep disorders and increased risk of dementia
por: Ferini‐Strambi, Luigi
Publicado: (2022) -
Comparable efficacy and safety of dimethyl fumarate and teriflunomide
treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word
multicenter experience
por: D’Amico, Emanuele, et al.
Publicado: (2018) -
COVID-19 in multiple sclerosis patients treated with dimethyl fumarate
por: Capone, Fioravante, et al.
Publicado: (2021) -
Multicenter Interventional Phase IV Study for the Assessment of the Effects on Patient's Satisfaction of Peg IFN Beta-1a (Pre-filled Pen) in Subjects With Relapsing–Remitting Multiple Sclerosis Unsatisfied With Other Injectable Subcutaneous Interferons (PLATINUM Study)
por: Centonze, Diego, et al.
Publicado: (2021)